Insider Transactions in Q1 2025 at Phreesia, Inc. (PHR)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2025
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
351
+0.74%
|
$9,828
$28.46 P/Share
|
|
Jan 31
2025
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
351
+0.84%
|
$9,828
$28.46 P/Share
|
|
Jan 31
2025
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
351
+0.94%
|
$9,828
$28.46 P/Share
|
|
Jan 29
2025
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
500
-0.22%
|
$14,500
$29.68 P/Share
|
|
Jan 28
2025
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
6,235
-4.09%
|
$174,580
$28.5 P/Share
|
|
Jan 27
2025
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
6,556
-2.08%
|
$177,012
$27.67 P/Share
|
|
Jan 27
2025
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,813
-1.62%
|
$129,951
$27.67 P/Share
|
|
Jan 27
2025
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,248
-1.02%
|
$708,696
$27.67 P/Share
|
|
Jan 27
2025
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,716
-0.69%
|
$289,332
$27.67 P/Share
|
|
Jan 27
2025
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
11,685
-2.43%
|
$315,495
$27.67 P/Share
|
|
Jan 27
2025
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,475
-1.48%
|
$93,825
$27.67 P/Share
|
|
Jan 24
2025
|
Yvonne Hui Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
127
-0.49%
|
$3,556
$28.0 P/Share
|
|
Jan 23
2025
|
Balaji Gandhi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,900
+5.01%
|
-
|
|
Jan 23
2025
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
12,791
+7.45%
|
-
|
|
Jan 23
2025
|
Evan Roberts Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,564
+2.46%
|
-
|
|
Jan 23
2025
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
19,564
+7.45%
|
-
|
|
Jan 23
2025
|
Chaim Indig Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,910
+3.66%
|
-
|
|
Jan 23
2025
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
7,900
+6.26%
|
-
|
|
Jan 21
2025
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,827
-3.95%
|
$157,329
$27.31 P/Share
|
|
Jan 21
2025
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
8,426
-5.45%
|
$227,502
$27.31 P/Share
|
|
Jan 21
2025
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,749
-1.66%
|
$344,223
$27.31 P/Share
|
|
Jan 21
2025
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
4,720
-4.1%
|
$127,440
$27.31 P/Share
|
|
Jan 21
2025
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
21,692
-1.72%
|
$585,684
$27.31 P/Share
|
|
Jan 21
2025
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
13,873
-5.85%
|
$374,571
$27.31 P/Share
|
|
Jan 15
2025
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
4,585
-1.45%
|
$119,210
$26.93 P/Share
|
|
Jan 15
2025
|
Yvonne Hui Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
381
-1.46%
|
$9,906
$26.87 P/Share
|
|
Jan 15
2025
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
604
-0.52%
|
$15,704
$26.98 P/Share
|
|
Jan 15
2025
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,990
-0.24%
|
$77,740
$26.98 P/Share
|
|
Jan 15
2025
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
836
-0.56%
|
$21,736
$26.98 P/Share
|
|
Jan 15
2025
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,785
-0.23%
|
$46,410
$26.98 P/Share
|
|
Jan 15
2025
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
1,946
-0.81%
|
$50,596
$26.98 P/Share
|
|
Jan 14
2025
|
Yvonne Hui Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
362
-1.37%
|
$9,412
$26.38 P/Share
|
|
Jan 10
2025
|
Yvonne Hui Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
388
-1.44%
|
$10,476
$27.85 P/Share
|
|
Jan 08
2025
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,681
-0.17%
|
$75,068
$28.07 P/Share
|
|
Jan 08
2025
|
Yvonne Hui Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
288
-1.06%
|
$8,064
$28.0 P/Share
|
|
Jan 07
2025
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,319
-0.94%
|
$197,613
$27.0 P/Share
|
|
Jan 06
2025
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,311
-1.12%
|
$34,086
$26.61 P/Share
|
|
Jan 06
2025
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,195
-2.11%
|
$83,070
$26.61 P/Share
|
|
Jan 06
2025
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,873
-0.37%
|
$74,698
$26.61 P/Share
|
|
Jan 06
2025
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
3,133
-1.29%
|
$81,458
$26.61 P/Share
|
|
Jan 06
2025
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
3,982
-2.44%
|
$103,532
$26.61 P/Share
|
|
Jan 06
2025
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,375
-0.42%
|
$139,750
$26.61 P/Share
|
|
Jan 02
2025
|
Chaim Indig Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,948
+3.57%
|
-
|
|
Jan 02
2025
|
Evan Roberts Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,990
+6.45%
|
-
|
|
Jan 02
2025
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
46,525
+22.19%
|
-
|
|
Jan 02
2025
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
53,990
+18.22%
|
-
|
|
Jan 02
2025
|
Balaji Gandhi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,990
+26.25%
|
-
|
|
Jan 02
2025
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
23,474
+16.72%
|
-
|